ACROPOSTITE-FIMOSE EM TOUROS – REVISÃO DE LITERATURA E RELATO DE CASO

A acropostite-fimose em touros se refere ao processo inflamatório da extremidade do prepúcio, afecção que pode resultar em incapacidade reprodutiva e perdas econômicas. Aspectos morfológicos do prepúcio de touros zebuínos (Bos indicus), fazem com que os mesmos sejam mais acometidos que raças taurinas (Bos taurus) e mestiços. O tratamento pode ser conservativo ou cirúrgico, dependendo do grau de comprometimento e cronicidade da lesão. Este trabalho apresenta revisão de literatura sobre acropostite-fimose e descreve o caso de um touro da raça Nelore submetido à postoplastia em “V”. A técnica cirúrgica utilizada demonstrou-se de fácil execução e eficaz em corrigir a afecção. O touro não apresentou complicações pós-operatórias e a atividade reprodutiva foi retomada em 60 dias

ANÁLISE SITUACIONAL DA ETIOLOGIA E TERAPÊUTICA DE PACIENTES COM INSUFICIÊNCIA CARDÍACA (IC) NO SISTEMA DE SAÚDE PÚBLICA

Objective: To evaluate the etiological and therapeutic reality of patients with HF in a care center of the Unified Health System (SUS) in the Municipality of Araguari-MG during the years 2017 to 2021. Methods: This is a retrospective cohort study, explanatory and documentary. Being an approach of quantitative variables, in which all medical records of the visits of the Cardiology of the Municipal Polyclinic were included, from 2017 to 2021, totaling 3,000 consultations from a total of 2,604 patients, 970 female and 1,634 male, and a confidence level of 95% was used, sampling error of 5% with a heterogeneous distribution totaling 600 medical records to be analyzed at random. Results: There was a prevalence of female sex (60%), the median age was 71 years. The most frequent etiology was hypertensive heart disease (75.6%), followed by ischemic heart disease (37.2%) and less common rheumatic fever (3.50%), with the most prescribed drugs being Beta-blockers (BB) (76 %), followed by Angiotensin Receptor Blockers (ARBs) (48.95%), loop diuretics (44.79%) and thiazides (44.79%). Conclusion: The treatment of patients treated at SUS is in accordance with the current Brazilian Guideline on Heart Failure.Objetivo: Evaluar la realidad etiológica y terapéutica de pacientes con IC en un centro de atención del Sistema Único de Salud (SUS) del Municipio de Araguari-MG durante los años 2017 a 2021. Métodos: Se trata de un estudio de cohorte retrospectivo, explicativo y documental. Siendo un abordaje de variables cuantitativas, en el que se incluyeron todas las historias clínicas de las visitas de Cardiología del Policlínico Municipal, desde el año 2017 al 2021, totalizando 3.000 consultas de un total de 2.604 pacientes, 970 del sexo femenino y 1.634 masculino, y un nivel de confianza Se utilizó el 95%, error de muestreo del 5% con una distribución heterogénea totalizando 600 historias clínicas para ser analizadas al azar. Resultados: Predominó el sexo femenino (60%), la mediana de edad fue de 71 años. La etiología más frecuente fue la cardiopatía hipertensiva (75,6 %), seguida de la cardiopatía isquémica (37,2 %) y menos frecuente la fiebre reumática (3,50 %), siendo los fármacos más prescritos los Betabloqueantes (BB) (76 %), seguidos por bloqueadores de los receptores de angiotensina (ARA) (48,95 %), diuréticos de asa (44,79 %) y tiazidas (44,79 %). Conclusión: El tratamiento de los pacientes atendidos en el SUS está de acuerdo con la actual Directriz Brasileña de Insuficiencia Cardíaca.Objetivo: Avaliar a realidade etiológica e terapêutica dos pacientes com IC em um Centro de atendimento do Sistema Único de Saúde (SUS) no Município de Araguari-MG durante os anos de 2017 a 2021. Métodos: Trata-se de um estudo coorte retrospectivo, explicativo e documental. Sendo uma abordagem de variáveis quantitativas, em que foram incluídos todos os prontuários dos atendimentos da Cardiologia da Policlínica Municipal, no período de 2017 a 2021, totalizando 3.000 consultas de um total de 2.604 pacientes, sendo 970 do sexo feminino e 1.634 do sexo masculino, e utilizou-se um nível de confiança de 95%, erro amostral de 5% com uma distribuição heterogênea totalizando 600 prontuários a serem analisados de forma aleatória. Resultados: Houve prevalência do sexo feminino (60%), a mediana de idades foi de 71 anos. A etiologia mais frequente foi cardiopatia hipertensiva (75,6%), seguida de cardiopatia isquêmica (37,2%) e menos comum a febre reumática (3,50%), sendo que os medicamentos mais prescritos foram Betabloqueadores (BB) (76%), seguidos pelos Bloqueadores de Receptores da Angiotensina (BRA) (48,95%), diuréticos de alça (44,79%) e tiazídicos (44,79%). Conclusão: A terapêutica dos pacientes atendidos no SUS está em concordância com a Diretriz Brasileira de Insuficiência Cardíaca vigente.Objetivo: Avaliar a realidade etiológica e terapêutica dos pacientes com IC em um Centro de atendimento do Sistema Único de Saúde (SUS) no Município de Araguari-MG durante os anos de 2017 a 2021. Métodos: Trata-se de um estudo coorte retrospectivo, explicativo e documental. Sendo uma abordagem de variáveis quantitativas, em que foram incluídos todos os prontuários dos atendimentos da Cardiologia da Policlínica Municipal, no período de 2017 a 2021, totalizando 3.000 consultas de um total de 2.604 pacientes, sendo 970 do sexo feminino e 1.634 do sexo masculino, e utilizou-se um nível de confiança de 95%, erro amostral de 5% com uma distribuição heterogênea totalizando 600 prontuários a serem analisados de forma aleatória. Resultados: Houve prevalência do sexo feminino (60%), a mediana de idades foi de 71 anos. A etiologia mais frequente foi cardiopatia hipertensiva (75,6%), seguida de cardiopatia isquêmica (37,2%) e menos comum a febre reumática (3,50%), sendo que os medicamentos mais prescritos foram Betabloqueadores (BB) (76%), seguidos pelos Bloqueadores de Receptores da Angiotensina (BRA) (48,95%), diuréticos de alça (44,79%) e tiazídicos (44,79%). Conclusão: A terapêutica dos pacientes atendidos no SUS está em concordância com a Diretriz Brasileira de Insuficiência Cardíaca vigente

Complicações Pós-Trauma: Gerenciando Edema Cerebral e Hipertensão Intracraniana

Introduction: The interconnection between cerebral edema and intracranial hypertension requires complex and rigorous monitoring, since cerebral edema directly influences the increase in intracranial pressure, resulting in a series of serious symptoms that can vary depending on the extent of the edema and other underlying factors. Objective: Understand complications arising from trauma and how to manage cerebral edema and intracranial pressure. Methodology: The Cochrane, Medline and Pubmed databases were used, searching for articles published between the years 2015 to 2023, in Portuguese or English. Conclusion: The treatment of these post-trauma conditions varies according to the clinical manifestations of each patient, therefore, obtaining an early diagnosis contributes to better monitoring and recovery.Introdução: A interconexão entre edema cerebral e hipertensão intracraniana aborda um acompanhamento complexo e rigoroso, uma vez que o edema cerebral influencia diretamente no aumento da pressão intracraniana, resultando em uma série de sintomas graves que podem variar dependendo da extensão do edema e de outros fatores subjacentes. Objetivo: Compreender as complicações decorrentes de traumas e como gerenciar o edema cerebral e a pressão intracraniana.  Metodologia: Foram utilizadas as bases de dados Cochrane, Medline e Pubmed, buscando artigos publicados entre os anos 2015 a 2023, nos idiomas Português ou Inglês. Conclusão: O tratamento dessas condições pós-trauma varia de acordo com o as manifestações clínicas de cada paciente, por isso, obter o diagnóstico precoce contribui para um melhor monitoramento e recuperação

Penilaian Kinerja Keuangan Koperasi di Kabupaten Pelalawan

This paper describe development and financial performance of cooperative in District Pelalawan among 2007 - 2008. Studies on primary and secondary cooperative in 12 sub-districts. Method in this stady use performance measuring of productivity, efficiency, growth, liquidity, and solvability of cooperative. Productivity of cooperative in Pelalawan was highly but efficiency still low. Profit and income were highly, even liquidity of cooperative very high, and solvability was good

Severe early onset preeclampsia: short and long term clinical, psychosocial and biochemical aspects

Preeclampsia is a pregnancy specific disorder commonly defined as de novo hypertension and proteinuria after 20 weeks gestational age. It occurs in approximately 3-5% of pregnancies and it is still a major cause of both foetal and maternal morbidity and mortality worldwide1. As extensive research has not yet elucidated the aetiology of preeclampsia, there are no rational preventive or therapeutic interventions available. The only rational treatment is delivery, which benefits the mother but is not in the interest of the foetus, if remote from term. Early onset preeclampsia (<32 weeks’ gestational age) occurs in less than 1% of pregnancies. It is, however often associated with maternal morbidity as the risk of progression to severe maternal disease is inversely related with gestational age at onset2. Resulting prematurity is therefore the main cause of neonatal mortality and morbidity in patients with severe preeclampsia3. Although the discussion is ongoing, perinatal survival is suggested to be increased in patients with preterm preeclampsia by expectant, non-interventional management. This temporising treatment option to lengthen pregnancy includes the use of antihypertensive medication to control hypertension, magnesium sulphate to prevent eclampsia and corticosteroids to enhance foetal lung maturity4. With optimal maternal haemodynamic status and reassuring foetal condition this results on average in an extension of 2 weeks. Prolongation of these pregnancies is a great challenge for clinicians to balance between potential maternal risks on one the eve hand and possible foetal benefits on the other. Clinical controversies regarding prolongation of preterm preeclamptic pregnancies still exist – also taking into account that preeclampsia is the leading cause of maternal mortality in the Netherlands5 - a debate which is even more pronounced in very preterm pregnancies with questionable foetal viability6-9. Do maternal risks of prolongation of these very early pregnancies outweigh the chances of neonatal survival? Counselling of women with very early onset preeclampsia not only comprises of knowledge of the outcome of those particular pregnancies, but also knowledge of outcomes of future pregnancies of these women is of major clinical importance. This thesis opens with a review of the literature on identifiable risk factors of preeclampsia

Search for heavy resonances decaying to two Higgs bosons in final states containing four b quarks

A search is presented for narrow heavy resonances X decaying into pairs of Higgs bosons (H) in proton-proton collisions collected by the CMS experiment at the LHC at root s = 8 TeV. The data correspond to an integrated luminosity of 19.7 fb(-1). The search considers HH resonances with masses between 1 and 3 TeV, having final states of two b quark pairs. Each Higgs boson is produced with large momentum, and the hadronization products of the pair of b quarks can usually be reconstructed as single large jets. The background from multijet and t (t) over bar events is significantly reduced by applying requirements related to the flavor of the jet, its mass, and its substructure. The signal would be identified as a peak on top of the dijet invariant mass spectrum of the remaining background events. No evidence is observed for such a signal. Upper limits obtained at 95 confidence level for the product of the production cross section and branching fraction sigma(gg -> X) B(X -> HH -> b (b) over barb (b) over bar) range from 10 to 1.5 fb for the mass of X from 1.15 to 2.0 TeV, significantly extending previous searches. For a warped extra dimension theory with amass scale Lambda(R) = 1 TeV, the data exclude radion scalar masses between 1.15 and 1.55 TeV

Measurement of the top quark mass using charged particles in pp collisions at root s=8 TeV

Peer reviewe

Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world

Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection

Measurement of associated W plus charm production in pp collisions at √s=7 TeV

Peer reviewe